跳至主要内容
临床试验/NCT02051595
NCT02051595已完成早期 1 期

The Effects of Modified Ultrafiltration on Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery

University of Florida2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2014年4月最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
已完成
入组人数
25
试验地点
2
主要终点
Circulating Vancomycin Concentration

研究概览

简要总结

Antibiotics are routinely used to prevent surgical wound infection. Vancomycin is a widely used antibiotic for surgery in patients with an allergy to penicillin. During cardiac surgery, cardiopulmonary bypass (CPB) and modified ultrafiltration (MUF) are routinely used and can lower the level of the antibiotic. The purpose of this study is to quantify the change in plasma vancomycin concentration associated with cardiopulmonary bypass and modified ultrafiltration.

详细描述

Subjects having cardiac surgery in which they will be on a heart-lung machine and will receive the antibiotic vancomycin, will be able to participate.

Up to ten blood samples testing for vancomycin concentrations will be collected in subjects administered vancomycin as prophylaxis before cardiac surgery with cardiopulmonary bypass and modified ultrafiltration. Participation will be complete once the cardiac surgery has been finished.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled to undergo cardiac surgery with cardiopulmonary bypass and modified ultrafiltration
  • age greater than 18 years old
  • penicillin allergy or in-hospital stay greater than 24 hours
  • normal renal function
  • normal liver function
  • absence of clinical and laboratory signs of infection

排除标准

  • vancomycin allergy
  • pregnancy
  • impaired renal function
  • impaired liver function
  • morbid obesity
  • active infections
  • Jehovah's Witness

研究组 & 干预措施

Vancomycin concentrations

Other

Up to ten blood samples testing for vancomycin concentrations will be collected in subjects administered vancomycin as prophylaxis before cardiac surgery with cardiopulmonary bypass and modified ultrafiltration.

干预措施: Vancomycin concentrations (Other)

结局指标

主要结局

Circulating Vancomycin Concentration

时间窗: Time points: pre CPB (t=1), post CPB at 5 (t=2), 30 (t=3), 60 (t=4), 108 (t=5), 240 (t=6) minutes, prior to ultrafiltration (t=7), end of ultrafiltration (t=8), ultrafiltrate (t=9) ,effluent of cell saver (t=10)

Blood samples to monitor the vancomycin concentration will be collected at several time points during surgery.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验